Rhythm Biosciences (ASX:RHY) Share Price and News

Market Cap (1-Jul) $15,908,536 (556th)	Close (30-Jun) $0.410 0 (0%)	Volume (30-Jun) 126,180	Shortsold (13-Dec) 12,817 (0.00%) (571st)
52w High $0.140	52w Low $0.042	P/E -	EPS -0.01

	Subject
	RHY RHY Ann: Notification of cessation of securities - RHY
	1 (current) 2 3
	RHY RHY Ann: Revised Securities Trading Policy
	RHY RHY Ann: Investor Presentation
	RHY RHY Ann: Rhythm Continues Platform Expansion Program for Other Cancer
	RHY RHY Ann: ColoSTAT Poster Presentation at ASCO Annual Meeting
	RHY RHY Ann: Notification of cessation of securities - RHY
	RHY RHY Ann: Response to ASX Query
	RHY RHY Ann: UK Strategic Partnership with LINK Medical Solutions
	RHY RHY Ann: Application for quotation of securities - RHY
	RHY RHY Ann: Cleansing Notice
	RHY RHY Ann: Application for quotation of securities - RHY
	RHY RHY Ann: Cleansing Notice
	RHY RHY Ann: UK CA Mark granted for ColoSTAT
	RHY RHY Ann: Form 604 - Change of Interests of Substantial Shareholder
	RHY RHY Ann: Change of Directors Interest Notice
	RHY RHY Ann: Notification of cessation of securities - RHY
	RHY RHY Ann: Appendix 4C and Market Update
	RHY RHY Ann: Appendix 3Z - Final Directors Interest Notice
	RHY RHY Ann: Executive Management Change
	RHY RHY Ann: ColoSTAT abstracts accepted at 2023 ASCO Annual Meeting
	RHY RHY Ann: Reinstatement to Official Quotation
	RHY RHY Ann: Update to TGA Submission
	RHY RHY Ann: Suspension from Official Quotation
	RHY RHY Ann: Trading Halt
	RHY RHY Ann: Pause in Trading
	RHY RHY Ann: Change of Share Registry Details
	RHY RHY Ann: Appendix 4D & Interim Financial Report
	RHY RHY Ann: RHY Institutional Presentation
	RHY RHY Ann: Rhythm Maintains ISO Certification
	RHY RHY Ann: Initial Director's Interest Notice
	RHY RHY Ann: Appendix 4C - Quarterly
	RHY RHY Ann: Appointment of New Non-Executive Director
	RHY RHY Ann: Institutional Presentation
	RHY RHY Ann: Change of Director's Interest Notice x 2
	RHY RHY Ann: Notification regarding unquoted securities - RHY
	RHY RHY Ann: Change of Directors Interest Notice x 4
	RHY RHY Ann: Notification of cessation of securities - RHY
	RHY RHY Ann: Institutional Presentation
	RHY RHY Ann: Market Update
	RHY RHY Ann: RHY Continues Platform Expansion Program for Other Cancers
	RHY RHY Ann: MST Access Diagnostics Forum Presentation (Amended)
	RHY RHY Ann: MST Access Financial Diagnostics Presentation
	RHY RHY Ann: MST Access Financial Diagnostics Presentation
	RHY RHY Ann: Final Director's Interest Notice
	RHY RHY Ann: RHY 2022 AGM Presentation
	RHY RHY Ann: Results of Meeting
	RHY RHY Ann: Mr. Eduardo Vom Retires as a Non-executive Director
	RHY RHY Ann: Application for quotation of securities - RHY
	RHY RHY Ann: Cleansing Notice
	RHY RHY Ann: Application for quotation of securities - RHY

Similar Companies

Apiam Animal Health

AHX

BARD1 Life Sciences

BD1

Capitol Health

CAJ

Healthia

HLA

Healius

HLS

Integral Diagnostics

IDX

Sonic Healthcare

SHL

SILK Laser Australia Ltd

SLA

Total Brain

TTB

End of Day Prices

Date	Close	Volume	Change
30-Jun	$0.05	740,853	0.00 (6.90%)
27-Jun	$0.06	616,457	+0.00 (1.75%)
26-Jun	$0.06	361,669	+0.00 (3.64%)
24-Jun	$0.06	1,103,992	0.00 (8.33%)
23-Jun	$0.06	339,372	0.00 (3.23%)
20-Jun	$0.06	573,318	0.00 (4.62%)
19-Jun	$0.07	436,097	+0.01 (8.33%)
18-Jun	$0.06	136,183	+0.00 (3.45%)
16-Jun	$0.06	61,022	0.00 (1.69%)
13-Jun	$0.06	196,507	0.00 (4.84%)
12-Jun	$0.06	382,633	0.00 (1.59%)
06-Jun	$0.06	64,239	0.00 (0.00%)
05-Jun	$0.06	53,779	+0.00 (3.28%)
04-Jun	$0.06	269,207	0.00 (0.00%)
03-Jun	$0.06	18,895	0.00 (3.17%)
5 up, 8 down, and 2 flat days

High $0.42	Low $0.41	Trades 28	Turnover $52,803	Volume 126,180
30 June 2023 at 3:42pm

High $0.42	Low $0.41	Trades 28	Turnover $52,803	Volume 126,180
30 June 2023 at 3:42pm

Rhythm Biosciences Health Care

$0.410 -0.010 (-2.38%)

$0.410 -0.010 (-2.38%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

RHY Rhythm Biosciences Health Care

$0.410 -0.010 (-2.38%)

$0.410 -0.010 (-2.38%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Rhythm Biosciences Health Care